Celecoxib
Pre-clinicalCompleted 0 watching 0 views this week💤 Quiet
23
Development Stage
1
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Patients With Traumatic Pain, Post-surgical Pain and Tooth Extract Pain
Conditions
Patients With Traumatic Pain, Post-surgical Pain and Tooth Extract Pain
Trial Timeline
Jul 1, 2012 → Apr 1, 2013
NCT ID
NCT01876121About Celecoxib
Celecoxib is a pre-clinical stage product being developed by Astellas Pharma for Patients With Traumatic Pain, Post-surgical Pain and Tooth Extract Pain. The current trial status is completed. This product is registered under clinical trial identifier NCT01876121. Target conditions include Patients With Traumatic Pain, Post-surgical Pain and Tooth Extract Pain.
Hype Score Breakdown
Clinical
5
Activity
2
Company
10
Novelty
2
Community
1
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01876121 | Pre-clinical | Completed |
Competing Products
20 competing products in Patients With Traumatic Pain, Post-surgical Pain and Tooth Extract Pain
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| R744 + R744 | Chugai Pharmaceutical | Phase 3 | 77 |
| R744 + R744 + rHuEPO + rHuEPO + R744 placebo + rHuEPO placebo | Chugai Pharmaceutical | Phase 3 | 77 |
| R744 + Epoetin beta | Chugai Pharmaceutical | Phase 3 | 77 |
| R744 + R744 | Chugai Pharmaceutical | Phase 3 | 77 |
| R744 + R744 | Chugai Pharmaceutical | Phase 3 | 77 |
| R744 | Chugai Pharmaceutical | Phase 3 | 77 |
| PLX3397 + Temozolomide | Daiichi Sankyo | Phase 1/2 | 41 |
| FK949E | Astellas Pharma | Phase 1 | 33 |
| roxadustat | Astellas Pharma | Phase 3 | 77 |
| roxadustat | Astellas Pharma | Phase 3 | 77 |
| Roxadustat + Darbepoetin alfa | Astellas Pharma | Phase 3 | 77 |
| ASP8825 | Astellas Pharma | Phase 1 | 33 |
| ASP015K | Astellas Pharma | Phase 1 | 33 |
| ASP7991 | Astellas Pharma | Phase 1 | 33 |
| Roxadustat + Epoetin Alfa | Astellas Pharma | Phase 3 | 77 |
| ATG-F | Astellas Pharma | Approved | 85 |
| roxadustat + Darbepoetin alfa | Astellas Pharma | Phase 3 | 77 |
| roxadustat | Astellas Pharma | Phase 3 | 77 |
| FK949E | Astellas Pharma | Phase 1 | 33 |
| ASP1585 | Astellas Pharma | Phase 2 | 52 |